Business Wire

VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System

29.7.2026 15:00:00 CEST | Business Wire | Press release

Share

VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system.

The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and treated by Dr. Konstantinos Voudris, MD, PhD, Director, Center for Valve and Structural Heart Disease.

Mike Buck, Chairman and CEO of VDyne, said; "Initiating our TRIVITA US IDE pivotal study represents an important milestone for VDyne following years of innovation by our dedicated team. The trial reflects our continued commitment to advancing treatment options for patients with TR and evaluating TriNova’s potential role in the evolving standard of care. As we rapidly activate new investigational sites and build enrollment momentum in TRIVITA, as well as continue enrollment in the ongoing VISTA US & VISTA Global trials, we are moving closer to our ambition of establishing TriNova as the preferred treatment option for TR patients globally."

“The benefits and importance of treating TR are quickly evolving as a growing number of patients seek treatment and TriNova represents a significant step forward in TR therapies, an outcome we intend to demonstrate through the US pivotal study,” commented Dr. Susheel Kodali, incoming Co-Director, Heart Valve Center at NYU Langone Medical Center and Study Chairman, Global Co-Principal Investigator for the TRIVITA pivotal study. “Enrolling the first patient in the US pivotal study brings hope for an improved standard of care. TriNova incorporates next-generation elements designed to offer unique side delivery and compatibility with tricuspid anatomy. The system is designed to operate independently of the leaflets & chordae, ensuring reliable annular anchoring and providing functional evaluation prior to final implantation.”

Dr Nadira Hamid, Director of Interventional Echocardiography at Minneapolis Heart Institute and Scientific Director of the Echocardiography Core Laboratory at Minneapolis Heart Institute Foundation and Global Co-Principal Investigator of the TRIVITA US pivotal study, added; "The start of the US pivotal study represents an important step forward in developing improved treatment options for patients with tricuspid regurgitation. The data from US/European/Australian/Canadian early feasibility studies (EFS) and the ongoing VISTA trials have been very encouraging and have provided promising preliminary safety and performance data of TriNova. I am looking forward to this next phase of the TriNova clinical program as we build enrollment momentum in the TRIVITA pivotal trial.”

TriNova is being evaluated through a comprehensive clinical development program, which includes the ongoing VISTA US EFS study (NCT05848284), the VISTA Global EFS study (NCT05797519), and now the TRIVITA pivotal IDE study (NCT07516444).

About VDyne Inc.
VDyne Inc. is a privately held medical device company based in Maple Grove, Minnesota, developing a transcatheter tricuspid valve replacement (TTVR) system for the treatment of tricuspid regurgitation.

VDyne’s TTVR system is currently under clinical investigation and is not approved for commercial sale in the United States or any other jurisdiction.

For more information, please visit www.vdyne.com.

TriNova is a trademark of VDyne Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260729729276/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Experian Recognized by Chartis Research for Advancing AI Model Governance in Quantitative Analytics50 202629.7.2026 15:00:00 CEST | Press release

Global data and technology company recognized for helping financial institutions accelerate AI innovation with trusted model governance, transparency and regulatory control Key Highlights Chartis Research recognized Experian as the category winner for Model Risk Management Environment in the Quantitative Analytics50 2026 report. Experian Ascend Platform™ enables organizations to move from model development to governed production with transparency, traceability and policy-driven controls. Recognition validates Experian's approach to helping lenders and financial institutions accelerate AI adoption while strengthening compliance, explainability and model risk governance. Experian today announced it has been recognized by Chartis Research as the winner in the Model Risk Management Environment category in the Quantitative Analytics50 2026 report. The recognition marks Experian's first appearance in the prestigious ranking and reinforces the company's position as a leading provider of data

Grid Dynamics Accelerates Enterprise AI-Native Transformation With Workforce Certification and GAIN Platforms Rollout29.7.2026 15:00:00 CEST | Press release

Key Takeaways: Grid Dynamics plans to have 90% of its engineers trained and certified on Anthropic and OpenAI platforms by the end of October 2026. At one of North America's largest home improvement retailers, Grid Dynamics has scaled its GAIN (Grid Dynamics AI Native) Platform for AI SDLC by expanding its agentic harness technology to more than 500 additional engineers. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a leading provider of technology consulting, platform and product engineering, and AI-driven digital transformation services, today announced significant momentum in the adoption of its enterprise agentic AI solutions. Organizations across retail, financial services, manufacturing, CPG, and logistics industries are increasingly deploying Grid Dynamics’ agentic AI-native platforms and Forward Deployed Engineering (FDE)-led services to accelerate software delivery, improve operational efficiency, and transform business processes at scale. Grid Dynamics is wid

New Continuous Delivery Loop Framework From Coherent Solutions Closes the AI Value Gap for Software Engineering Teams Moving From AI-Assisted to AI-Native Development29.7.2026 15:00:00 CEST | Press release

The company's early results show an approximately 30% delivery-performance gain when AI tool adoption is paired with operating model change Software teams are generating code faster than ever with AI, yet many see the bottleneck shifting to delivery speed and code quality. Coherent Solutions, a global digital engineering firm, argues in its recent whitepaper that the problem lies in traditional SDLC processes that aren't built for AI's speed. It introduces an operating framework designed to close that gap, called the Continuous Delivery Loop (CDL). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729426213/en/ New Continuous Delivery Loop framework from Coherent Solutions The whitepaper, “From traditional SDLC to the Continuous Delivery Loop,” is available to download for free. The whitepaper also describes what the company calls the "Digital Value Gap," which exists between accelerated developer activity and actual busines

Arendt Launches AVA, Its Proprietary AI-powered Prospectus Compliance Review Tool29.7.2026 14:54:00 CEST | Press release

Arendt & Medernach, the leading independent Luxembourg-based law firm specialising in business law, investment funds, corporate law and tax, announced the launch of AVA (Arendt Visa Agent), a proprietary, purpose-built AI solution designed for UCITS prospectus compliance review. Developed in-house and built on Arendt's own legal knowledge and methodology, with the technical architecture delivered in close collaboration with a specialist AI technology partner, AVA marks a key milestone in Arendt's innovation strategy and reinforces its commitment to leveraging advanced technology to support its clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729264434/en/ The scale of the challenge Arendt has developed AVA, an AI-driven compliance tool that draws on the firm's unparalleled market intelligence in UCITS – built over decades of advising fund managers, boards and service providers on Luxembourg's most complex prospectu

Copeland Enters into Exclusive Negotiations to Acquire Dickson, Advancing Cold Chain Leadership29.7.2026 14:00:00 CEST | Press release

Proposed acquisition will expand Copeland’s presence across the healthcare and life sciences cold chain, adding environmental monitoring, compliance expertise and cloud-based monitoring capabilities Copeland, a global leader in compression technologies and controls solutions, today announced its entry into exclusive negotiations towards the purchase of Dickson, a portfolio company of May River Capital and provider of environmental monitoring and cloud-native software solutions for regulated life sciences and healthcare applications. The proposed acquisition will strengthen Copeland’s strategy of enabling an efficient and effective cold chain, building on its existing stationary and in-transit monitoring capabilities to deliver an end-to-end solution that helps healthcare, pharmaceutical and life sciences customers safeguard product integrity, maintain compliance and reduce operational risk. Quality assurance and environmental monitoring represents a large and secularly growing market o

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye